Kyndryl Investors Face April 13 Deadline as Securities Suits Mount Over Control Failures

Investors are being urged to seek lead‑plaintiff status by the court‑set date as New York cases focus on alleged internal‑control weaknesses, misstated cash metrics, and SEC scrutiny.

Overview

Multiple securities class actions are pending in the Eastern and Southern Districts of New York, including Brander v. Kyndryl (No. 26‑cv‑00782) and a later Westchester Putnam Counties case (No. 26‑cv‑02211) that expanded the class period.
Filings allege failures to disclose material information, with complaints citing deferred vendor payments to influence free cash flow metrics, misstated financials, and ineffective internal control over financial reporting.
On February 9, 2026, Kyndryl said it could not timely file its Form 10‑Q for the quarter ended December 31, 2025 and anticipated reporting material weaknesses, including issues tied to information and communication controls and tone at the top.
Kyndryl also disclosed the immediate departures of its CFO and general counsel and noted voluntary document requests from the SEC’s Division of Enforcement.
The stock fell $12.90, about 55%, to close at $10.59 on February 9, 2026, and investors who bought shares from August 1, 2024 through February 9, 2026 have until April 13, 2026 to seek lead‑plaintiff status.